Kidney Diseases Completed Phase 2 Trials for Alemtuzumab (DB00087)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00001984Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted KidneysTreatment